Уважаемые пользователи!

Данный сайт содержит информацию для людей с медицинским образованием и специалистов здравоохранения.
Входя на сайт, Вы подтверждаете свое согласие с Условиями использования и Политикой конфиденциальности.



Dear visitor!
This site contains medical information for healthcare professionals.
You can go further, if you agree with Terms and Conditions and Privacy Policy on this site.

Vol 56, No 5 (2010)

Epidemiology of primary hyperparathyroidism
Dedov I.I., Vasil'eva T.O., Rozhinskaia L.I., Mokrysheva N.G.
Problems of Endocrinology. 2010;56(5):3-7
views808
ACTH-producing neuroendocrine chest wall tumours
Marova E.I., Kokshagina N.V., Rozhinskaia L.I.
Problems of Endocrinology. 2010;56(5):8-14
views928
Late consequences of long-term glucocorticoid therapy in patients with congenital adrenal cortical dysfunction
Molashenko N.V., Sazonova A.I., Troshina E.A., Kalinchenko N.I.
Problems of Endocrinology. 2010;56(5):15-22
views694
Functional state of the hypothalamic-pituitary-gonadal axis in diabetes mellitus
Shpakov A.O.
Problems of Endocrinology. 2010;56(5):23-29
views1665
The risk of development of prostatic hyperplasia and prostate cancer in patients presenting with acromegalia
Rozhivanov R.V., Fabrichnova A.A., Lepetukhin A.E., Dubskiĭ S.A., Kurbatov D.G.
Problems of Endocrinology. 2010;56(5):30-32
views638
Peculiarities of pathogenesis, diagnostics and treatment of erectile dysfunction in patients presenting with hypogonadism
Gamidov S.I., Tazhetdinov O.K., Pavlovichev A.A., Popova A.I., Tkhagapsoeva R.A.
Problems of Endocrinology. 2010;56(5):33-42
views767
The importance of combined glycemic control in patients with type 2 diabetes mellitus
Kononenko I.V., Smirnova O.M.
Problems of Endocrinology. 2010;56(5):43-51
views769
Extension of the group of incretin-targeted preparations: Saxagliptin – a new dipeptidyl peptidase-4 inhibitor
Shestakova M.V., Sukhareva O.I.
Problems of Endocrinology. 2010;56(5):52-60
views643
Results of the observational program on the use of insulin glargine (Lantus) in combination with oral hypoglycemic agents or prandial insulins for the treatment of type 2 diabetes mellitus in routine clinical practice
Glinkina I.V.
Problems of Endocrinology. 2010;56(5):61-66
views723

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies